These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17433874)

  • 1. The T cell repertoire in infection and vaccination: implications for control of persistent viruses.
    Davenport MP; Price DA; McMichael AJ
    Curr Opin Immunol; 2007 Jun; 19(3):294-300. PubMed ID: 17433874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune dysfunction following infection with chicken anemia agent and infectious bursal disease virus. II. Alterations of in vitro lymphoproliferation and in vivo immune responses.
    Cloud SS; Rosenberger JK; Lillehoj HS
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):353-66. PubMed ID: 1333677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New viral vectors for infectious diseases and cancer.
    Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
    Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing positive and negative regulation of T cell activity during viral persistence.
    Fahey LM; Brooks DG
    Curr Opin Immunol; 2010 Jun; 22(3):348-54. PubMed ID: 20381328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.
    Holst PJ; Jensen BA; Ragonnaud E; Thomsen AR; Christensen JP
    PLoS One; 2015; 10(2):e0117242. PubMed ID: 25679375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosenescence: what does it mean to health outcomes in older adults?
    McElhaney JE; Effros RB
    Curr Opin Immunol; 2009 Aug; 21(4):418-24. PubMed ID: 19570667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection.
    Makedonas G; Betts MR
    Springer Semin Immunopathol; 2006 Nov; 28(3):209-19. PubMed ID: 16932955
    [No Abstract]   [Full Text] [Related]  

  • 8. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players.
    Oldstone MB
    Virology; 1997 Aug; 234(2):179-85. PubMed ID: 9268148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development.
    Balz K; Trassl L; Härtel V; Nelson PP; Skevaki C
    Front Immunol; 2020; 11():513. PubMed ID: 32296430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominant viral peptides as determinants of cross-reactivity in the immune system--Can we develop wide spectrum viral vaccines?
    Vieira GF; Chies JA
    Med Hypotheses; 2005; 65(5):873-9. PubMed ID: 16051445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage.
    He L; De Groot AS; Gutierrez AH; Martin WD; Moise L; Bailey-Kellogg C
    BMC Bioinformatics; 2014; 15 Suppl 4(Suppl 4):S1. PubMed ID: 25104221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral memory T cell responses: correlation with protective immunity and implication for vaccine development.
    Harari A; Ellefsen K; Champagne P; Nobile M; Pantaleo G
    Adv Exp Med Biol; 2002; 512():155-64. PubMed ID: 12405200
    [No Abstract]   [Full Text] [Related]  

  • 13. Keystone conference on viral immunity: from basic mechanisms to vaccines (X7) and advances in influenza research: from birds to bench to bedside (X8) Steamboat Springs, Colorado March 28-April 2, 2006.
    Liu F; Slifka MK
    Viral Immunol; 2006; 19(3):584-9. PubMed ID: 16987078
    [No Abstract]   [Full Text] [Related]  

  • 14. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections.
    Ha SJ; West EE; Araki K; Smith KA; Ahmed R
    Immunol Rev; 2008 Jun; 223():317-33. PubMed ID: 18613845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wanted, dead or alive: new viral vaccines.
    Amanna IJ; Slifka MK
    Antiviral Res; 2009 Nov; 84(2):119-30. PubMed ID: 19733596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing innate and adaptive immunity for viral vaccine design.
    Jost S; Altfeld M; Chang JJ
    Expert Rev Vaccines; 2012 Jul; 11(7):775-7. PubMed ID: 22913253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines.
    Kim SJ; Sung HW; Han JH; Jackwood D; Kwon HM
    Vet Microbiol; 2004 Jun; 101(1):39-51. PubMed ID: 15201032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector and memory CTL differentiation.
    Williams MA; Bevan MJ
    Annu Rev Immunol; 2007; 25():171-92. PubMed ID: 17129182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell-inducing vaccines - what's the future.
    Gilbert SC
    Immunology; 2012 Jan; 135(1):19-26. PubMed ID: 22044118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.